Health Catalyst CEO granted 2.75M RSUs, buys stock

Health Catalyst’s CEO received a large RSU inducement grant and bought additional shares in the open market on September 14, 2026.

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) reported that Chief Executive Officer and director Simeon Kohl received a grant of 2,747,385 restricted stock units (RSUs) on September 14, 2026 under the company’s 2026 Employment Inducement Incentive Plan. 915,975 RSUs vest on September 4, 2027, with the remaining RSUs vesting in eight approximately equal quarterly installments thereafter, subject to plan terms. On the same date, he also purchased 59,000 shares of common stock at $1.7871 per share in a direct transaction. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Net Buyer: 59,000 shares

Net Buy 2 txns

Insider Kohl Simeon

Role Chief Executive Officer

Bought 59,000 shs ($105K)

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	2,747,385	$0.00	$0.00
Purchase	Common Stock	59,000	$1.7871	$105K

Holdings After Transaction: Common Stock — 2,856,385 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments.

Key Figures

RSUs granted: 2,747,385 units Initial RSUs vesting: 915,975 units Quarterly vesting installments: 8 installments +2 more

5 metrics

RSUs granted 2,747,385 units Restricted stock units awarded to CEO on September 14, 2026

Initial RSUs vesting 915,975 units Portion of RSUs vesting on September 4, 2027

Quarterly vesting installments 8 installments Remaining RSUs vest in approximately equal quarterly installments after September 4, 2027

Shares purchased 59,000 shares Common stock purchased directly by CEO on September 14, 2026

Purchase price $1.7871 per share Price paid for 59,000 common shares

Key Terms

restricted stock units, Employment Inducement Incentive Plan, vesting

3 terms

restricted stock units financial

"Represents an award of restricted stock units ("RSUs") granted pursuant"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employment Inducement Incentive Plan financial

"granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan"

An employment inducement incentive plan is a package of stock, options or other long-term pay given to a new hire to persuade them to join and stay, similar to a signing bonus paid in company shares rather than cash. For investors, these awards matter because they can dilute existing shareholders, add to compensation expense, and align the new employee’s decisions with shareholder value—so they signal how a company is investing in key talent.

vesting financial

"915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did HCAT’s CEO report on September 14, 2026?

Simeon Kohl reported a grant of 2,747,385 RSUs under Health Catalyst’s 2026 Employment Inducement Incentive Plan and a purchase of 59,000 common shares at $1.7871 per share, both on September 14, 2026.

How do the new RSUs for HCAT’s CEO vest?

Of the 2,747,385 RSUs, 915,975 RSUs vest on September 4, 2027. After that date, the remaining RSUs vest in eight approximately equal quarterly installments, subject to the terms of the 2026 Employment Inducement Incentive Plan.

What is the size of the RSU award granted to HCAT’s CEO?

The award to Simeon Kohl consists of 2,747,385 restricted stock units (RSUs), each representing a contingent right to receive one share of Health Catalyst’s common stock, granted under the 2026 Employment Inducement Incentive Plan.

At what price did HCAT’s CEO buy common stock in this Form 4?

Simeon Kohl purchased 59,000 shares of Health Catalyst common stock at a price of $1.7871 per share in a direct transaction dated September 14, 2026.

Was the HCAT CEO’s September 14, 2026 trading under a Rule 10b5-1 plan?

The filing indicates that no Rule 10b5-1 trading plan is reported for these transactions, as the document-level 10b5-1 checkbox is not affirmed.

What does each RSU granted to HCAT’s CEO represent?

Each RSU in the 2,747,385-unit grant represents a contingent right to receive one share of Health Catalyst’s common stock, subject to the vesting schedule and other terms of the 2026 Employment Inducement Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:53 PM Accepted by SEC EDGAR 09/16/2026 - 04:52 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kohl Simeon

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY, #300

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		A		2,747,385(1)	A	$0.00	2,797,385	D
Common Stock	09/14/2026		P		59,000	A	$1.7871	2,856,385	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)